Skip to main content

Posts

Showing posts from November, 2019

Desmoid Tumors Market Drugs, Developments, Clinical Research and Major Investments in Healthcare

MRFR Estimated That  “Desmoid Tumors Market Is Expected to Grow at a CAGR 4.5% During the Forecast Period Of 2017-2023”. Desmoid Tumors Market Overview Desmoid tumors are the benign fibrous growths which usually develops in the fibrous tissue of the body, commonly in the arms, legs or midsection, and sometimes in the head and neck. According to the U.S National Library of Medicine, Desmoid tumors are very rare as the rate of occurrence is estimated to be 1 to 2 per 500,000 people worldwide. It is also stated that nearly 900 to 1,500 new cases are registered per year in the United States. Tumors associated with familial adenomatous polyposis (FAP) are less common than sporadic desmoid tumors. On the molecular level, desmoid tumor is characterized by one of the two mutations in the gene i.e. mutations in the adenomatous polyposis coli (APC) gene, or in the β-catenin gene, CTNNB1. During diagnostic procedures CTNNB1 mutation is detected, especially, when pathological differe

Drug Discovery Overview For Genu recurvatum Condition and Treatment Analysis

Genu recurvatum is also known as knee hyperextension or back knee. It is a type of condition that affects the knee joint to bend backward when the person is in standing position. This problem is more common in women than in men and commonly identified in 0.5%-1.0% of patients undergoing Total knee arthroplasty (TKA).   Genu recurvatum can also cause other conditions such as knee pain or knee osteoarthritis. Genu recurvatum can be mild, moderate, or severe. This deformity can also arise from other medical conditions such as, quadriceps weakness, bone deformities, paralysis, plantar foot flexion, and high tibial osteotomies. Genu recurvatum can be congenital or acquired. Congenital genu recurvatum (CGR) is extremely rare condition and found to be associated with other malformations such as talipes equinovarus, hip dysplasia, and absent patella.   High cost of treatment & management genu recurvatum and related disorders, and lack of infrastructure in the middle- and low-inco

Latest Drugs Scenario and NEW Discovery in Dupuytren's contracture Disease

Dupuytren's contracture is a condition in which there is difficulty in articulating fingers due to formation of tissue knots under the skin. In severe conditions, the fingers become permanently bent in a flexed position. Dupuytren's contracture is typically not painful and generally affects the ring finger followed by the little and middle finger. The exact causes of Dupuytren's contracture are unknown however the risk factors include alcoholism, smoking, thyroid problems, liver disease, diabetes, previous hand trauma, epilepsy, family history etc. The market drivers for Dupuytren’s contracture market are, increase in risk factors rising incomes, growing screening, increasing geriatric population etc. The market restraints are cost of Dupuytren’s contracture surgery, complications and risk of the surgery, invasive nature of treatment, and regression of the disease even after treatment etc. The  global Dupuytren’s contracture market is expected to reach USD 5.5 billion

Upcoming Drugs of Vasectomy Diagnosis, Industry Size, Treatment and Trends 2019

The “ Global  Vasectomy Market Size  Is Expected to Reach USD 24.0 Billion at a CAGR of ~ 7.1 % During the By the End of Forecast Period 2017-2023 ”. Vasectomy is male sterilization surgery, which involves severing the male vas deferens to prevent sperm from entering into the urethra. It is a permanent procedure of preventing fertilization as reversal is costly and often does not restore the male's fertility. The advantages of minimal invasive surgical procedures such as low hospital stay, low trauma and surgical footprint, less pain has resulted in greater demand for minimal invasive procedures and thus, greater acceptance. Vasectomy Market Segmental Analysis: The global vasectomy market has been segmented on the basis of type, drug, patient, and end user. Based on the type , the market has been segmented as conventional vasectomy, no-scalpel vasectomy, and minimally invasive vasectomy. Based on the drug , the market has been segmented as anesthetics, pain

xanthoma Treatment, Drugs, Diagnosis, Technology and Trends By Types

The global xanthoma market is expected to reach USD 8.0 billion by 2023, and the market is projected to grow at a CAGR of ~ 6.0 % during the forecast period 2017-2023. Xanthoma is a dermatology condition characterized by fatty growth underneath the skin.  There may be clusters of growths in the same area or several individual growths on different parts of the body.   The exact causes of xanthoma is unknown, however, genetic factors have been indicated a cause of this conditions such as cogenosis type 1a, autosomal recessive hypercholesterolemia, alagille syndrome, and cholesterol storage disease. Get Free Sample Copy at   https://www.marketresearchfuture.com/sample_request/4860 Market Competitive Some of the key players profiled in the report are AstraZeneca PLC GlaxoSmithKline PLC Johnson & Johnson Bayer HealthCare Pharmaceuticals LLC Pfizer Inc. Novartis International AG Teva pharmaceutical industries Novo Nordisk Sanofi and others

Latest Drugs and Treatment Technology for Chondroplasty (Damaged cartilage)

Chondroplasty is a surgery of damaged cartilage with an aim to reduce friction in joints such as knee joint.  The recent developments in the chondroplasty treatment includes development of radio frequency chondroplasty which uses radio frequency waves to fill cracks and wedges in the cartilage structure and to stimulate growth. There is also an increasing trend towards miniaturization of devices. Development of alloys have advanced the shavers and made them more efficient to ensure less trauma to the tissue being treated. Free Sample Copy Download at  https://www.marketresearchfuture.com/sample_request/4205 Competitive Analysis: Key players profiled in the report are – Braun Melsungen AG NuOrtho Surgical Inc. Zimmer Biomet Holdings Inc. Smith & Nephew plc Nebula Inc. Gpcmedical Osiris Therapeutics Inc. Sklar Surgical Instruments Stryker Corporation and others. Intended Audience Global Chondroplasty treatment manufacturers & suppliers Research

New Research on Tissue Tranglutaminase Testing (tTG) Research Insights 2019 BY Types, Technology and Trends

Tissue Tranglutaminase Test Industry Overview on  The  Tissue Tranglutaminase Test Industry  is expected to grow at a CAGR of ~17.5% during the forecast period. Download Free sample copy at  https://www.marketresearchfuture.com/sample_request/824 Competitive Analysis: Quest Diagnostics Incorporated. SQI Diagnostics Trinity Biotech ZEDIRA GmbH Demeditec Diagnostics GmbH ARUP Laboratories Cell Science Systems Bio-Rad Laboratories Inc. Pfizer Inc. Celimmune LLC. and others. Market Segmentation: The global Tissue Tranglutaminase Testing Industry has been segmented on the basis types and end users. Based on types, the market has been segmented into serological, biopsy testing, and others. The serological testing is sub-segmented into tissue transglutaminase (tTG) antibody- IgA, serum and tissue transglutaminase (tTG) antibody- IgG, serum. Based on the end users, the market has been segmented as hospitals & clinics, homecare, research organizations, a

Whipple’s Rare disease New Drug Discovery and Latest Industry Growth Prospects 2019

Whipple’s disease (WD) is a rare, chronic, systemic infectious bacterial disease caused by Tropheryma whipplei that affects gastrointestinal system, especially, the small intestine. The infection may spread to any part of the body but mostly it affects the central nervous system, joints, lungs, heart, and eyes. Ongoing research and clinical trial to find effective cure drive the growth of market. Advancement in medical technology and increasing awareness about this disease boost the market growth. Avail a Free Sample Copy at  https://www.marketresearchfuture.com/sample_request/4094 The  “global Whipple’s Disease Industry is expected to grow at the CAGR of ~3.1% during the forecast period and is estimated to reach USD 255.3 million by 2023.” Competitive Analysis: Some of the key players in this market are – AbbVie Inc. (US) Allergan (Republic of Ireland) Bayer AG (Germany) Bristol-Myers Squibb Company (US) Hoffmann-La Roche Ltd. (Switzerland) Henry Schein

Latest MRFR Brief on metastases spinal tumor Industry is growing moderately in Upcoming Years

The global metastases spinal tumor Industry is growing moderately, and it is expected to grow at the same pace over the forecast period. Early diagnosis can provide better treatment management of this disorder. Major diagnostic solution provider companies are engaged in developing and launching new medical imaging devices. Introduction and rapid adoption of advanced diagnostic devices are driving the market growth. The global market of metastases spinal tumor was around USD 1241.5 million in 2016 and is expected to reach USD 1547.8 million by 2023 at a projected CAGR of 3.2%. Avail a Free Sample Copy at  https://www.marketresearchfuture.com/sample_request/4084 Competitive Analysis: Some of the key players in this market are – Hoffmann-La Roche Ltd (Switzerland) Amgen Inc. (US) Novartis AG(Switzerland) Abbott (US) Beckman Coulter Inc. (US) Debiopharm Group (Switzerland) AbbVie Inc. (US) Bayer AG (Germany) and others. Market Segments The global meta

Retinal Treatment on Detachment Industry Growth, Size and Technology Analysis

Global Retinal Detachment Industry Share Is Expected to Grow at The CAGR of ~5.9% During the Forecast Period and Is Estimated to Reach USD 2689.2 Million By 2023 . Some of the key players in this market are:  Carl Zeiss Meditec, Inc. (US), Centervue SpA (Italy), Co:Lab Pensacola (US), Eyenuk Inc (US), Imagine Eyes (France), HealPros, LLC (US), NEUROVISION IMAGING, LLC . (US), Optos (UK), Peek Vision Ltd. (UK), and others. Retinal detachment is sever medical condition and medical emergency. Early diagnosis and treatment is very important to cure retinal detachment. Some of the common symptoms of retinal detachment are partial vision loss, blurred vision, suddenly seeing many floaters, and others. Retinal detachment can affect people of any age but it is more common in older adults aged from 60-70. Changing technology is another important factor for the market growth. Introduction and rapid adoption of technologically advanced products are helping in effective diagnosis and tr

Radiation Protection Apparels Market Trends, Demand Penetration, Growth Factors, Industry Insights by Top Key Players

The global radiation protection apparels market is currently dominated by many market players. The major players in the market are involved in new product launches and strategic collaborations to strengthen its market position.  It is estimated that the global r adiation protection apparels market is expected to register a market value of USD 473 million in 2017, with a CAGR ~ 7.2% during the forecast period of 2018–2023 . Several factors such as increase in strict safety regulations by various government agencies such as Occupational Safety and Health Administration (OSHA), and National Institute for Occupational Safety and Health (NIOSH), and increase in the number of medical imaging processes are luring the growth of the market.   radiation protection apparels market  Segmentation The global radiation protection apparels market has been segmented into product type, material, and end user. The market, based on product type, has been segmented into aprons, gloves, he

Hypodontia Market Statistics, Business Opportunities, Key Players Review by Clinical Professionals

Hypodontia or selective tooth agenesis is the failure to form one or more teeth during the developmental period. 2.6%–11% of the population across the globe suffers from this condition. The exact cause of the condition remains unknown. Increasing number of patients suffering from hypodontia drives the growth of the market. Additionally, increasing prevalence of different dental diseases have increased the demand for different treatments and boosted the growth of the market. During last decade, a number of different treatments and diagnostic devices were introduced to improve the prognosis of the condition. Well developed technology has supported the growth of the market in this region, however, high cost of the treatment may slow the market growth. The global hypodontia market is expected to grow at a CAGR of 6.2% during the forecast period 2017-2023.   Hypodontia Market  Key Players: The key players for the global hypodontia   market Companies are Patterson Dental (U.S.